Eric Topol/LinkedIn
May 31, 2026, 15:41
Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
Eric Topol, Founder and Director of Scripps Research Translational Institute, shared a post on X about a recent article by Xiaqing Jiang et al., published in The Lancet, adding:
”The p-tau217 breakthrough blood test replicated again, predicting Alzheimer’s disease in a large cohort mean age 61.
The cover of the new issue is telling.”
Title: Alzheimer’s disease neuropathology plasma biomarkers and cognition in midlife: a community-based cohort study
Authors: Xiaqing Jiang, Tina D Hoang, Prof Leslie M Shaw, Prof David R Jacobs, Ilya M Nasrallah, Prof R Nick Bryan, Prof Kristine Yaffe
Other posts featuring Eric Topol on Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session